InDex Pharmaceuticals Holding AB
STO:FLERIE
Intrinsic Value
The intrinsic value of one FLERIE stock under the Base Case scenario is 5.14 SEK. Compared to the current market price of 41.7 SEK, InDex Pharmaceuticals Holding AB is Overvalued by 88%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
InDex Pharmaceuticals Holding AB
Fundamental Analysis

Revenue & Expenses Breakdown
InDex Pharmaceuticals Holding AB
Balance Sheet Decomposition
InDex Pharmaceuticals Holding AB
Current Assets | 1B |
Cash & Short-Term Investments | 802.1m |
Receivables | 225.5m |
Other Current Assets | 5.8m |
Non-Current Assets | 2.9B |
Long-Term Investments | 100k |
PP&E | 800k |
Other Non-Current Assets | 2.9B |
Free Cash Flow Analysis
InDex Pharmaceuticals Holding AB
SEK | |
Free Cash Flow | SEK |
Earnings Waterfall
InDex Pharmaceuticals Holding AB
Revenue
|
100k
SEK
|
Cost of Revenue
|
-20.9m
SEK
|
Gross Profit
|
-20.8m
SEK
|
Operating Expenses
|
-89.1m
SEK
|
Operating Income
|
-109.9m
SEK
|
Other Expenses
|
-219.5m
SEK
|
Net Income
|
-329.4m
SEK
|
FLERIE Profitability Score
Profitability Due Diligence
InDex Pharmaceuticals Holding AB's profitability score is 18/100. The higher the profitability score, the more profitable the company is.
Score
InDex Pharmaceuticals Holding AB's profitability score is 18/100. The higher the profitability score, the more profitable the company is.
FLERIE Solvency Score
Solvency Due Diligence
InDex Pharmaceuticals Holding AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
InDex Pharmaceuticals Holding AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FLERIE Price Targets Summary
InDex Pharmaceuticals Holding AB
According to Wall Street analysts, the average 1-year price target for FLERIE is 51.51 SEK with a low forecast of 44.44 SEK and a high forecast of 59.85 SEK.
Dividends
Current shareholder yield for FLERIE is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one FLERIE stock under the Base Case scenario is 5.14 SEK.
Compared to the current market price of 41.7 SEK, InDex Pharmaceuticals Holding AB is Overvalued by 88%.